2017: Volume 1, Issue 1
Commentary P.4-4
Commentary on a Case Study "A Life with and beyond Cancer".
Author(s): Jan Sitvast*, Guido Bogert and Ingrid Bogert
Case Blog P.5-6
Acute tumor lysis syndrome after anti-pd-1 immunotherapy nivolumab for metastatic melanoma.
Author(s): Daniel Brunnhoelzl and Jue Wang*
Review Article P.7-13
The psychoneuroimmunotherapy of human immune-mediated systemic diseases, including cancer and autoimmune diseases
Author(s): Lissoni P, Messina G*, Tantarelli R, Lissoni A, Tantarelli O, Pellegrino G, Rovelli F, Di Fede G
Review Article P.14-21
Immunoaffinity binding for separation of circulating tumor cells with microfluidic chips.
Author(s): Hongmei Chen*, Baoshan Cao, Hongda Chen, Xiaoqing Lv, Lei Li
Case Report P.45-46
Melanoma associated with chronic leg ulcer: Case report.
Author(s): Wilson Onuigbo*, Frank Akpuaka
Research Article P.47-52
EBV LMP1 regulates cancer growth through IRF-7 in nasopharyngeal carcinoma.
Author(s): Jianguo Wu*, Dongsheng Xu, Qian Cheng, Luwen Zhang, Dan Cheng, Jing Zhao
Review Article P.53-63
Hyperglycosylated hCG drives malignancy in cancer cases.
Author(s): Laurence A. Cole
Review Paper P.65-73
Quantification of newer anticancer drug enzalutamide by stability indicating RP-LC method and UV-visible spectroscopic method in bulk and synthetic mixture.
Author(s): Dharmendra J Prajapati*, Usmangani K. Chhalotiya, Minesh D. Prajapati, Jalpa U. Patel, Harsha V. Patel